Cardiovascular pathology provides valuable insights into the risk factors, progression, and complications associated with cardiovascular diseases. It aids in the identification of novel biomarkers and targets for therapeutic interventions. The field encompasses a wide range of techniques, including histopathology, immunohistochemistry, and molecular pathology, to unravel the intricate details of cardiac and vascular pathology at the cellular and molecular levels. Cardiovascular pathologists collaborate with clinicians, radiologists, and researchers to contribute to the interdisciplinary understanding of cardiovascular diseases, guiding patient care and advancing medical knowledge. The findings from cardiovascular pathology research are integral to improving diagnostic accuracy, predicting disease outcomes, and informing the development of targeted therapies, ultimately aiming to reduce the global burden of cardiovascular diseases.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India